Gary J. Nabel

2.9k total citations · 1 hit paper
18 papers, 2.5k citations indexed

About

Gary J. Nabel is a scholar working on Immunology, Molecular Biology and Virology. According to data from OpenAlex, Gary J. Nabel has authored 18 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Molecular Biology and 6 papers in Virology. Recurrent topics in Gary J. Nabel's work include HIV Research and Treatment (6 papers), Immune Cell Function and Interaction (5 papers) and T-cell and Retrovirus Studies (4 papers). Gary J. Nabel is often cited by papers focused on HIV Research and Treatment (6 papers), Immune Cell Function and Interaction (5 papers) and T-cell and Retrovirus Studies (4 papers). Gary J. Nabel collaborates with scholars based in United States and United Kingdom. Gary J. Nabel's co-authors include S L Kunkel, L Osborn, Anthony Sanchez, Zhiyong Yang, E G Nabel, Nancy J. Sullivan, Henricus J. Duckers, Kwanyee Leung, Neil D. Perkins and Colin S. Duckett and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Gary J. Nabel

18 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.

1989 1.5k citations L Osborn, S L Kunkel et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Gary J. Nabel

Since Specialization

Citations

This map shows the geographic impact of Gary J. Nabel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary J. Nabel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary J. Nabel more than expected).

Fields of papers citing papers by Gary J. Nabel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary J. Nabel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary J. Nabel. The network helps show where Gary J. Nabel may publish in the future.

Co-authorship network of co-authors of Gary J. Nabel

This figure shows the co-authorship network connecting the top 25 collaborators of Gary J. Nabel. A scholar is included among the top collaborators of Gary J. Nabel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary J. Nabel. Gary J. Nabel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Rational Design of Vaccines to Elicit Broadly Neutralizing Antibodies to HIV-1 2011 ·Cold Spring Harbor Perspectives in Medicine ·Peter D. Kwong, John R. Mascola, Gary J. Nabel	120
2	Antibodies and Resistance to Natural HIV Infection 2000 ·New England Journal of Medicine ·Gary J. Nabel, (unknown)	16
3	Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. 2000 ·Nature Medicine ·Gary J. Nabel, Zhiyong Yang, Henricus J. Duckers, Nancy J. Sullivan, Anthony Sanchez, E G Nabel	312
4	Genetic Vaccination-Induced Immune Responses to the Human Immunodeficiency Virus Protein Rev: Emergence of the Interleukin 2-Producing Helper T Lymphocyte 1998 ·Human Gene Therapy ·Sherri Y. Chan, Marisa C. Louie, Joseph R. Piccotti, Geetha Iyer, Ling Xu, Zhi-Yong Yang, Gary J. Nabel, D. Keith Bishop	4
5	1Organizers: Elizabeth G. Nabel and Inder Verma.2Organizers: Philip L. Felgner, Frank Szoka, Leaf Huang and Ernst Wagner.Keystone Symposia on: Molecular and Cellular Biology of Gene Therapy1 and Synthetic Non-Viral Gene Delivery Systems2 1998 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Gary J. Nabel, Peter Hobart	1
6	Injection of HHV-8 in human skin engrafted on SCID mice induces kaposi's sarcoma (KS)-like lesions 1998 ·Journal of Dermatological Science ·Kimberly E. Foreman, Jacques Friborg, Gary J. Nabel, B J Nickoloff	2
7	Kaposi’s Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor Confers Resistance to the Antiproliferative Effect of Interferon-α 1998 ·Molecular Medicine ·C. Clay Flowers, (unknown), Gary J. Nabel	43
8	Comparison of HHV-8 derived from Kaposis sarcoma and body cavity based lymphoma 1997 ·Journal of Investigative Dermatology ·Kimberly E. Foreman, Jeppe Friborg, C. Clay Flowers, (unknown), Gary J. Nabel, Brian J. Nickoloff	3
9	Distinct domains of adenovirus E1A interact with specific cellular factors to differentially modulate human immunodeficiency virus transcription 1997 ·Journal of Virology ·(unknown), Lisa K. Felzien, Neil D. Perkins, Michael J. Imperiale, Gary J. Nabel	22
10	A New Cationic Liposome DNA Complex Enhances the Efficiency of Arterial Gene Transfer In Vivo 1996 ·Human Gene Therapy ·Dominique Stéphan, Zhi-Yong Yang, Hong San, Robert D. Simari, Carl J. Wheeler, Philip L. Felgner, David Gordon, Gary J. Nabel, Elizabeth G. Nabel	92
11	A cooperative interaction of human T-cell leukemia virus type 1 Tax with the p21 cyclin-dependent kinase inhibitor activates the human immunodeficiency virus type 1 enhancer 1996 ·Journal of Virology ·(unknown), Neil D. Perkins, Scott D. Gitlin, Gary J. Nabel	15
12	Regulation of human retroviral latency by the NF-kappa B/I kappa B family: inhibition of human immunodeficiency virus replication by I kappa B through a Rev-dependent mechanism. 1995 ·Proceedings of the National Academy of Sciences ·Bei Wu, Clive Woffendin, Colin S. Duckett, Takeshi Ohno, Gary J. Nabel	29
13	Positive and negative regulation of IL-2 gene expression: Role of multiple regulatory sites 1994 ·Cytokine ·(unknown), Gary J. Nabel	18
14	Dissociation of endogenous cellular ceramide from NF-kappa B activation. 1994 ·Journal of Biological Chemistry ·Jonathan C. Betts, Adam B. Agranoff, Gary J. Nabel, James A. Shayman	61
15	Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation. 1992 ·Proceedings of the National Academy of Sciences ·Neil D. Perkins, (unknown), Colin S. Duckett, Kwanyee Leung, Nancy R. Rice, Gary J. Nabel	226
16	Tumor necrosis factor-α, interleukin 1, and phorbol myristate acetate are independent activators of NF-κB which differentially activate T cells 1991 ·Cytokine ·(unknown), (unknown), Kwanyee Leung, Laurelee Osborn, (unknown), Gary J. Nabel	50
17	Induction of NF-χB during monocyte differentiation is associated with activation of HIV-gene expression 1991 ·Research in Virology ·George E. Griffin, Kai P. Leung, T M Folks, S L Kunkel, Gary J. Nabel	47
18	Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. breakdown → 1989 ·Proceedings of the National Academy of Sciences ·L Osborn, S L Kunkel, Gary J. Nabel	1485

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact